Weekly Intelligence · 5 articles

Vet Industry Intel: Apr 26 – May 2, 2026

High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.

Regulatory & Policy (4) Products & Technology (1)

Regulatory & Policy

Apr 30, 2026 [9/10] DVM360

Generic drug for treating internal parasites in sheep receives FDA approval

The U.S. Food and Drug Administration approved a generic drug for treating internal parasites in sheep.

FDA · DVM360

Apr 30, 2026 [9/10] Dallas Express

FDA Approves First Chewable Amlodipine For Cats: New Treatment For Feline Hypertension

The U.S. Food and Drug Administration approved the first chewable amlodipine formulation for cats, providing a new treatment option for feline hypertension.

FDA · Dallas Express · Amlodipine | TX

Apr 29, 2026 [9/10] DVM360

FDA approves first veterinary amlodipine drug for feline hypertension

The FDA approved the first veterinary-specific amlodipine drug for the treatment of feline hypertension.

FDA · DVM360

Apr 27, 2026 [8/10] DVM360

FDA authorizes Negasunt Powder for New World screwworm under emergency use

The FDA granted emergency use authorization for Negasunt Powder to treat New World screwworm infestations.

FDA · Negasunt Powder · DVM360

Products & Technology

May 1, 2026 [7/10] DVM360

Weekly Vet Report: FDA approves feline hypertension drug, injectable BOAS therapy shows early promise, and more

The FDA recently approved a new feline hypertension drug, and an injectable therapy for BOAS has shown early clinical promise.

FDA · DVM360